Feasibility and preliminary efficacy of tantalum components in the management of acetabular reconstruction following periacetabular oncologic resection in primary malignancies

Table 1 Demographic characteristics of the included patients

No.	Sex	Age (years)	Side	Diagnosis	Enneking zone	Prosthesis type	Follow-up (months)	Complications	MSTS-93 score	HHS score
1	M	42	Right	Chondrosarcoma	II + III	Cup, buttress, augments	42	None	26	88
2	F	36	Right	Chondrosarcoma	II	Cup, buttress	41	None	25	86
3	F	47	Left	Chondrosarcoma	I + II	Cup, buttress	37	None	22	85
4	M	51	Left	Osteosarcoma	I + II + III	Cup, buttress, augments	38	None	21	84
5	F	44	Right	Chondrosarcoma	I + II + III	Cup, buttress, augments	45	Delayed wound healing	23	82
6	M	47	Left	MBGCT	II + III	Cup, augments	40	None	23	76
7	M	53	Left	Osteosarcoma	I + II + III	Cup, buttress, augments	43	Dislocation	19	60
8	F	48	Right	Chondrosarcoma	II + III	Cup, augments	38	None	26	91
9	M	64	Left	Chondrosarcoma	I + II	Cup, buttress	38	None	25	88
10	F	55	Right	Chondrosarcoma	II + III	Cup, augments	37	Relapse, hemi-pelvic amputation	12	46
11	F	33	Right	Chondrosarcoma	I + II	Cup, buttress	44	None	26	92
12	M	56	Right	MBGCT	II + III	Cup-cage, augments	42	None	23	76
13	M	36	Left	Osteosarcoma	I + II + III	Cup, buttress, augments	39	Pulmonary metastasis	18	73
14	M	52	Left	MBGCT	I + II + III	Cup, buttress, augments	36	Dislocation	18	78
15	F	45	Right	Chondrosarcoma	II + III	Cup, augments	35	None	20	81

M male, F female, MBGCT malignant bone giant cell tumor, MSTS-93 1993 Musculoskeletal Tumor Society Scale, HHS Harris Hip Scores, MSTS-93 score and HSS score were evaluated 1-year postoperatively

ISSN: 2047-783X